SARS-CoV-2 and the Use of Chloroquine as an Antiviral Treatment
Front Med (Lausanne)
.
2020 Apr 24:7:184.
doi: 10.3389/fmed.2020.00184.
eCollection 2020.
Authors
Mathieu E Rebeaud
1
,
Florian Zores
2
Affiliations
1
DBMV, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
2
Groupe médical spécialisé, Strasbourg, France.
PMID:
32391371
PMCID:
PMC7193267
DOI:
10.3389/fmed.2020.00184
No abstract available
Keywords:
2019-nCoV; COVID-19; SARS-CoV-2; antiviral; chloroquine.